July 10, 2009
Our STN: BL 103914/5249
Sanofi Pasteur Inc.
Attention: Joseph H. Quinn
Swiftwater, PA 19370
Dear Mr. Quinn:
We have approved your request to supplement your biologics license application for Influenza Virus Vaccine, Fluzone®, to include the 2009-2010 United States formulation.
Please submit all final printed labeling at the time of use and include implementation information on FDA form 356h. Please provide PDF-format electronic copies of these labels.
We will include the information contained in the above referenced supplement in your Biologics License Application file.
Jerry P. Weir, Ph.D.
Division of Viral Products
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research
Attachment: Approved Final Draft Labeling